Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 268

1.

Conditional disruption of calcineurin B1 in osteoblasts increases bone formation and reduces bone resorption.

Yeo H, Beck LH, Thompson SR, Farach-Carson MC, McDonald JM, Clemens TL, Zayzafoon M.

J Biol Chem. 2007 Nov 30;282(48):35318-27. Epub 2007 Sep 19.

2.

Calcineurin/NFAT signaling in osteoblasts regulates bone mass.

Winslow MM, Pan M, Starbuck M, Gallo EM, Deng L, Karsenty G, Crabtree GR.

Dev Cell. 2006 Jun;10(6):771-82.

3.

Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast.

Oshima K, Nampei A, Matsuda M, Iwaki M, Fukuhara A, Hashimoto J, Yoshikawa H, Shimomura I.

Biochem Biophys Res Commun. 2005 Jun 3;331(2):520-6.

PMID:
15850790
4.

Targeted disruption of nuclear factor erythroid-derived 2-like 1 in osteoblasts reduces bone size and bone formation in mice.

Kim J, Xing W, Wergedal J, Chan JY, Mohan S.

Physiol Genomics. 2010 Jan 8;40(2):100-10. doi: 10.1152/physiolgenomics.00105.2009. Epub 2009 Nov 3.

5.

Disruption of the insulin-like growth factor type 1 receptor in osteoblasts enhances insulin signaling and action.

Fulzele K, DiGirolamo DJ, Liu Z, Xu J, Messina JL, Clemens TL.

J Biol Chem. 2007 Aug 31;282(35):25649-58. Epub 2007 Jun 6.

6.

Impaired bone formation in transgenic mice resulting from altered integrin function in osteoblasts.

Zimmerman D, Jin F, Leboy P, Hardy S, Damsky C.

Dev Biol. 2000 Apr 1;220(1):2-15.

7.

Increased bone formation in mice lacking apolipoprotein E.

Schilling AF, Schinke T, Münch C, Gebauer M, Niemeier A, Priemel M, Streichert T, Rueger JM, Amling M.

J Bone Miner Res. 2005 Feb;20(2):274-82. Epub 2004 Nov 1.

8.

Deficiency of chemokine receptor CCR1 causes osteopenia due to impaired functions of osteoclasts and osteoblasts.

Hoshino A, Iimura T, Ueha S, Hanada S, Maruoka Y, Mayahara M, Suzuki K, Imai T, Ito M, Manome Y, Yasuhara M, Kirino T, Yamaguchi A, Matsushima K, Yamamoto K.

J Biol Chem. 2010 Sep 10;285(37):28826-37. doi: 10.1074/jbc.M109.099424. Epub 2010 Jun 22.

9.

Bone loss induced by Runx2 over-expression in mice is blunted by osteoblastic over-expression of TIMP-1.

Schiltz C, Prouillet C, Marty C, Merciris D, Collet C, de Vernejoul MC, Geoffroy V.

J Cell Physiol. 2010 Jan;222(1):219-29. doi: 10.1002/jcp.21941.

PMID:
19780057
10.

Expression and activity of osteoblast-targeted Cre recombinase transgenes in murine skeletal tissues.

Liu F, Woitge HW, Braut A, Kronenberg MS, Lichtler AC, Mina M, Kream BE.

Int J Dev Biol. 2004 Sep;48(7):645-53.

11.

Osteoblast-targeted expression of Sfrp4 in mice results in low bone mass.

Nakanishi R, Akiyama H, Kimura H, Otsuki B, Shimizu M, Tsuboyama T, Nakamura T.

J Bone Miner Res. 2008 Feb;23(2):271-7.

12.

Mode of growth hormone action in osteoblasts.

DiGirolamo DJ, Mukherjee A, Fulzele K, Gan Y, Cao X, Frank SJ, Clemens TL.

J Biol Chem. 2007 Oct 26;282(43):31666-74. Epub 2007 Aug 13.

13.

Collagen1alpha1 promoter drives the expression of Cre recombinase in osteoblasts of transgenic mice.

Zha L, Hou N, Wang J, Yang G, Gao Y, Chen L, Yang X.

J Genet Genomics. 2008 Sep;35(9):525-30. doi: 10.1016/S1673-8527(08)60072-7.

PMID:
18804071
14.

Conditional deletion of Bmpr1a in differentiated osteoclasts increases osteoblastic bone formation, increasing volume of remodeling bone in mice.

Okamoto M, Murai J, Imai Y, Ikegami D, Kamiya N, Kato S, Mishina Y, Yoshikawa H, Tsumaki N.

J Bone Miner Res. 2011 Oct;26(10):2511-22. doi: 10.1002/jbmr.477.

15.

Osteoblast-targeted overexpression of TAZ increases bone mass in vivo.

Yang JY, Cho SW, An JH, Jung JY, Kim SW, Kim SY, Kim JE, Shin CS.

PLoS One. 2013;8(2):e56585. doi: 10.1371/journal.pone.0056585. Epub 2013 Feb 18.

16.

Bone morphogenetic protein type IA receptor signaling regulates postnatal osteoblast function and bone remodeling.

Mishina Y, Starbuck MW, Gentile MA, Fukuda T, Kasparcova V, Seedor JG, Hanks MC, Amling M, Pinero GJ, Harada S, Behringer RR.

J Biol Chem. 2004 Jun 25;279(26):27560-6. Epub 2004 Apr 16.

17.

Pseudomonas aeruginosa lipopolysaccharide induces osteoclastogenesis through a toll-like receptor 4 mediated pathway in vitro and in vivo.

Zhuang L, Jung JY, Wang EW, Houlihan P, Ramos L, Pashia M, Chole RA.

Laryngoscope. 2007 May;117(5):841-7.

PMID:
17473680
18.

Conditional deletion of gremlin causes a transient increase in bone formation and bone mass.

Gazzerro E, Smerdel-Ramoya A, Zanotti S, Stadmeyer L, Durant D, Economides AN, Canalis E.

J Biol Chem. 2007 Oct 26;282(43):31549-57. Epub 2007 Sep 4.

19.

Osteoblast-targeted overexpression of PPARγ inhibited bone mass gain in male mice and accelerated ovariectomy-induced bone loss in female mice.

Cho SW, Yang JY, Her SJ, Choi HJ, Jung JY, Sun HJ, An JH, Cho HY, Kim SW, Park KS, Kim SY, Baek WY, Kim JE, Yim M, Shin CS.

J Bone Miner Res. 2011 Aug;26(8):1939-52. doi: 10.1002/jbmr.366.

20.

Canonical Wnt signaling in osteoblasts is required for osteoclast differentiation.

Glass DA 2nd, Karsenty G.

Ann N Y Acad Sci. 2006 Apr;1068:117-30.

PMID:
16831912

Supplemental Content

Support Center